Helptext

Movies



Company Information

Company NameEurocine Vaccines AB
Company Idea

Eurocine Vaccines is a publicly listed, clinical-stage company developing nasal vaccines that meet important medical needs. The vaccines are developed up to proof of concept (clinical phase I/II) and licensed to partners for further development and commercialization. The company's proprietary vaccine adjuvant technologies, which are a key element of the nasal vaccines, are also offered to license partners for development in various indications.

Present focus is on partnering the nasal influenza vaccine program, Immunose™ FLU, which has shown proof of concept in a clinical study, and on preclinical development of a nasal vaccine against bacterial pneumonia.

Phone070-634 0171CEOHans Arwidsson
E-mailinfo(snabel-a)eurocine-vaccines(punkt)comChairm. of the BoardMichael Wolff Jensen
Homepagehttp://www.eurocine-vaccines.com 

Instrument Information

Full NameEurocine VaccinesShort NameEUCI
No of shares53,458,721Par Value0.11 SEK
TypeShareISIN codeSE0001839069

Price Information

+/-(0.11)
%-2.77
Latest3.86
High4.00
Low3.83
Volume100,978
Turnover (SEK)392,753
Market Cap (MSEK)206

Orders

VolumeBidAskVolume

Deals

TimeBuyerSellerPriceVolume
5:22 PMNONAVA3.86760
5:18 PMNONAVA3.86100
5:11 PMNONAVA3.861,500
4:56 PMDDBAVA3.83618
4:53 PMDDBAVA3.83252
4:53 PMAIVAVA3.84298
4:42 PMMLIAVA3.851,933
4:42 PMAVAAVA3.853,067
4:17 PMAVAMLI3.91250
4:12 PMSWBMLI3.922,000

Scheduled Reports

DateReport
2017-08-23Bokslutskommuniké för 2016/2017




  • Mäster Samuelsgatan 42
  • 111 57 Stockholm
  • Telefon: 08 - 511 68 000
  • info(snabel-a)aktietorget(punkt)se